Discover open access scientific publications

Search, annotate, share and cite publications

Publications by F.O. Le Brun

Reduction of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan in the Randomized Controlled Trial Seraphin

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Related publications

Correction to Figures In: Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Characterizing Patients Treated With Macitentan for Pulmonary Arterial Hypertension (PAH) in the U.S. Opsumit Users Registry (OPUS)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Anastrozole in Pulmonary Arterial Hypertension (AIPH): A Randomized, Double-Blind Placebo-Controlled Trial

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

P2 In-Flight Hypoxaemia in Patients With Pulmonary Arterial Hypertension (PAH)

Thorax
PulmonaryRespiratory Medicine
2011English

Hospitalization Costs Related to Pulmonary Hypertension (Ph) Among Medicare Advantage or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Therapeutic Challenges and Advances in the Management of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)

Therapeutics and Clinical Risk Management
2019English

Neprilysin Inhibition for Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial

British Journal of Pharmacology
Pharmacology
2019English

Development of a New Patient-Reported Outcome (PRO) Instrument for Pulmonary Arterial Hypertension (PAH): The Pulmonary Arterial Hypertension–symptoms and Impact (PAH-SYMPACT) Questionnaire

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy